Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
Additional Paid-In Capital
$595.09 Mil (As of Mar. 2016)

Progenics Pharmaceuticals Inc's quarterly additional paid-in capital increased from Sep. 2015 ($593.55 Mil) to Dec. 2015 ($594.51 Mil) and increased from Dec. 2015 ($594.51 Mil) to Mar. 2016 ($595.09 Mil).

Progenics Pharmaceuticals Inc's annual additional paid-in capital increased from Dec. 2013 ($548.51 Mil) to Dec. 2014 ($589.83 Mil) and increased from Dec. 2014 ($589.83 Mil) to Dec. 2015 ($594.51 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Progenics Pharmaceuticals Inc Annual Data

AdditionalPaidInCapital 321.32401.50422.09439.94453.35463.44493.61548.51589.83594.51

Progenics Pharmaceuticals Inc Quarterly Data

AdditionalPaidInCapital 548.51586.73588.13588.75589.83590.64592.15593.55594.51595.09
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)